Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the ...

At the four new sites, Lilly expects to create more than 3,000 jobs for engineers, scientists, operations personnel, and lab technicians.

Verve Therapeutics remains a high-reward investment despite setbacks. Click here to find out why VERV stock is a Buy.

New measles cases have been confirmed in New Jersey and Kentucky with the one common factor being a lack of measles ...

One highlight of the month is Kidney Action Week ®, which will be held March 3-7. The premiere national online conference for the kidney community, Kidney Action Week brings together people living ...

Eli Lilly is making a massive $50 billion investment in U.S. manufacturing. This move more than doubles their previous $23 ...

Eli Lilly (LLY) joins hands with Magnet Biomedicine in a deal worth up to $1.25B to develop cancer drugs using Magnet's ...

Eli Lilly is seeking to further cement its stance as a leader in weight loss drugs in an ad campaign calling out “unapproved” medications.

The company is doubling plans for capital spending on U.S. factories as President Donald Trump pressures the pharma industry ...

Rare Disease Day, an annual gathering hosted by the FDA and National Institutes of Health, was postponed. Medicare spending on 10 diabetes drugs, including popular GLP-1s, more than quadrupled over a ...

Lilly plans to build four new pharmaceutical plants in the US, creating 13,000 jobs and bringing its recent domestic ...